ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

about

Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance

P2860

Q58587352-31542E89-59E8-477B-B0A5-F4A82A8BD8ED

P2860

ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q40576732

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

ASXL1 and JAK2V617F gene mutat ...... with chronic myeloid leukemia.

@en

type

Item

label

ASXL1 and JAK2V617F gene mutat ...... with chronic myeloid leukemia.

@en

prefLabel

ASXL1 and JAK2V617F gene mutat ...... with chronic myeloid leukemia.

@en

P1476

ASXL1 and JAK2V617F gene mutat ...... with chronic myeloid leukemia

@en

P2093

Alireza Farshchi

http://www.w3.org/2001/XMLSchema#string

Amir Valikhani

http://www.w3.org/2001/XMLSchema#string

Behzad Poopak

http://www.w3.org/2001/XMLSchema#string

Ehsan Saraf Kazeruoni

http://www.w3.org/2001/XMLSchema#string

Ghasem Azizi Tabesh

http://www.w3.org/2001/XMLSchema#string

Naser Amirizadeh

http://www.w3.org/2001/XMLSchema#string

Shirin Ferdowsi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

A method and server for predicting damaging missense mutations

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

The biology of CML blast crisis.

P304

e41-e47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12588

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S H Ghaffari

Negar Rezaei

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27640403

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

about

P2860

P2860

ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921